Panbela Therapeutics Inc (PBLA)

NASDAQ
0.510
+0.022(+4.51%)
After Hours
0.530
+0.020(+3.922%)
- Real-time Data
  • Volume:
    488,925
  • Day's Range:
    0.480 - 0.530
  • 52 wk Range:
    0.411 - 87.600

PBLA Overview

Prev. Close
0.488
Day's Range
0.48-0.53
Revenue
-
Open
0.481
52 wk Range
0.411-87.6
EPS
-67.91
Volume
488,925
Market Cap
7.44M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,733,221
P/E Ratio
-0.01
Beta
1.06
1-Year Change
-99.4%
Shares Outstanding
14,595,873
Next Earnings Date
15 May 2023
What is your sentiment on Panbela Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Panbela Therapeutics Inc Company Profile

Panbela Therapeutics Inc Company Profile

Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing disruptive therapeutics for the treatment of patients with cancer. Its primary focus is on the treatment of patients with pancreatic cancer. Its lead product candidate, SBP-101, is a polyamine analogue designed to induce polyamine metabolic inhibition (PMI) by exploiting an observed high affinity of the compound for pancreatic ductal adenocarcinoma, ovarian cancer and other tumors. The Company is conducting Phase Ia/Ib study of the safety, tolerability and pharmacokinetics of SBP-101 when administered in combination with gemcitabine and nab-paclitaxel.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsStrong SellBuyBuyStrong SellStrong Sell
SummaryStrong SellNeutralNeutralStrong SellStrong Sell